Non-criteria aPL such as (anti-vimentin/aCL and anti-phosphatidylserine/prothrombin) could cross the gap between APS and seronegative APS in diagnosis, prognosis, and treatment6. This evidence concerns the gene F2 and autoimmune polyendocrinopathy.